Search

Displaying results 2471 - 2480 of 8974 in total
  1. Drug

    Equine Botulinum Neurotoxin E Immune FAB2

    go.drugbank.com/drugs/DB13897
    Approved

    It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes E in adults and pediatric patients.

  2. Drug

    Equine Botulinum Neurotoxin C Immune FAB2

    go.drugbank.com/drugs/DB13898
    Approved

    It is intravenously administered for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes C in adults and pediatric patients.

  3. Drug

    Teclistamab

    go.drugbank.com/drugs/DB16655
    ApprovedInvestigational

    cells to promote T cell–mediated cytotoxicity. … [A253587] On August 24, 2022, the European Commission (EC) granted conditional marketing authorization of teclistamab as first-in-class bispecific antibody for the treatment of multiple myeloma, marking

    Categories: Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager
  4. Indication

    Acquired Aplastic Anaemia

    go.drugbank.com/conditions/DBCOND0055951
    Drugs: Oxymetholone
    Synonyms: Anaemia: [acquired aplastic] or [normocytic due to aplasia]
  5. Indication

    Acute Hepatic Porphyria (AHP)

    go.drugbank.com/conditions/DBCOND0109617
    Drugs: Givosiran · Hematin
    Synonyms: Porphyria due to delta-aminolevulinate dehydratase deficiency
  6. Drug

    Nuvaxovid

    go.drugbank.com/drugs/DB15810
    ApprovedInvestigational

    [A243789, A243794, A243799] The European Commission granted Novavax conditional marketing authorization for nuvaxovid for active immunization to prevent COVID-19 caused by SARS-CoV-2 on December 20, … [L40548,L40553] On July 13, 2022, nuvaxovid was granted an emergency use authorization by the FDA for the prevention of COVID-19 in adults, which was expanded to include patients ≥12 years of age in August

  7. Drug

    Isoniazid

    go.drugbank.com/drugs/DB00951
    ApprovedInvestigational

    It remains the treatment of choice for tuberculosis.

    Mixtures: TB VIT 6, PRO TB 4Categories: Antiinfectives for Systemic Use, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  8. Drug

    Dengue virus serotype 4

    go.drugbank.com/drugs/DB22667
    Approved

    [A274008] It is one of four serotypes covered by Qdenga, a live, attenuated, tetravalent vaccine used for the prevention of dengue disease. … Dengue virus serotype 4 is a serotype of _Orthoflavivirus denguei_ known to cause dengue fever.

  9. Drug

    Lisinopril

    go.drugbank.com/drugs/DB00722
    ApprovedInvestigational

    Lisinopril is an angiotensin converting enzyme inhibitor (ACEI) used to treat hypertension, heart failure, and myocardial infarction. … [A184853] It functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system.

    Mixtures: SINORETIK FORT 20 MG/25 MG TABLET, 30 ADET, Co-Acetan - TablettenCategories: Antihypertensive Agents Indicated for Hypertension, Compounds used in a research, industrial, or household setting
  10. Indication

    Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

    go.drugbank.com/conditions/DBCOND0080506
    Drugs: Polatuzumab vedotin
    Synonyms: Malignant lymphoma, large B-cell, diffuse, no International Classification of Diseases for Oncology subtype